Medication info
Levacam Tablet 20/160 mg

Levacam Tablet 20/160 mg

Prescription medicationTabletOral
Ingredient · strength
Lercanidipine Hydrochloride›20mg / 1 tabletValsartan›160mg / 1 tablet
Manufacturer / importer
LG Chem, Co., Ltd.
Appearance
Pink oval film-coated tablet
Packaging
100 tablets (10 tablets/PTP x 10)
Approval status
Active

MFDS item code 201308392 · Approved 2013.07.25 · Insurance code 668902570

Summary

Main use
Treatment of essential hypertension not controlled with lercanidipine monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose is 1 tablet once daily, taken with water at least 15 minutes before a meal. If possible, it is recommended to take this medicine at the same time each day (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using lercanidipine. However, if blood pressure is not controlled, switching directly to this medicine may be considered as follows. - 10/80 mg: For patients whose blood pressure is not adequately controlled with lercanidipine 10 mg. - 10/160 mg: For patients whose blood pressure is not adequately controlled with lercanidipine 10 mg or this medicine 10/80 mg. - 20/160 mg: For patients whose blood pressure is not adequately controlled with this medicine 10/160 mg. ° Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment; however, caution is required when increasing the daily dose of lercanidipine to 20mg. This medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients receiving dialysis. ° Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg, and caution is required when increasing the daily dose of lercanidipine to 20mg. This medicine should not be administered to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. ° Elderly patients: In patients aged 65 years or older, start treatment at a low dose and administer with caution while monitoring the patient's condition.
Child dose
Use of this medicine is not recommended in pediatric patients under 18 years of age because its safety and efficacy have not been established.

Ingredients

Manufacturer
LG Chem, Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with lercanidipine monotherapy

  • Essential hypertension
View approved original text

In patients with essential hypertension, when blood pressure control is insufficient with Lercanidipine monotherapy, additional therapy may be needed. This medication helps lower blood pressure; however, if it is insufficient alone, it can be used in combination with other medications to manage blood pressure. It is primarily used for treating essential hypertension and contributes to reducing cardiovascular risk by adequately controlling the patient's blood pressure.

How to take

Adult dose

The recommended dose is 1 tablet once daily, taken with water at least 15 minutes before a meal. If possible, it is recommended to take this medicine at the same time each day (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using lercanidipine. However, if blood pressure is not controlled, switching directly to this medicine may be considered as follows. - 10/80 mg: For patients whose blood pressure is not adequately controlled with lercanidipine 10 mg. - 10/160 mg: For patients whose blood pressure is not adequately controlled with lercanidipine 10 mg or this medicine 10/80 mg. - 20/160 mg: For patients whose blood pressure is not adequately controlled with this medicine 10/160 mg. ° Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment; however, caution is required when increasing the daily dose of lercanidipine to 20mg. This medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients receiving dialysis. ° Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg, and caution is required when increasing the daily dose of lercanidipine to 20mg. This medicine should not be administered to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. ° Elderly patients: In patients aged 65 years or older, start treatment at a low dose and administer with caution while monitoring the patient's condition.

Child dose

Use of this medicine is not recommended in pediatric patients under 18 years of age because its safety and efficacy have not been established.

Precautions

This medication can cause serious harm or death to the fetus and newborn if taken during the second and third trimesters of pregnancy, so it should be stopped immediately if pregnancy is confirmed. Patients with a known allergy to this medication or its components, women who are pregnant or breastfeeding, patients with severe liver or kidney disease, and patients with certain heart conditions should not take this medication. Elderly patients, patients with high potassium levels, patients with impaired liver function, and patients with heart or kidney disease should take this medication with caution and monitor their condition closely as advised by a physician. This medication may cause various side effects such as headache, dizziness, dyspepsia, palpitations, skin rash, cough, etc., so if unusual symptoms appear, consult a healthcare professional immediately. During the initial stages of treatment, blood pressure may drop sharply, leading to dizziness or fainting; therefore, caution is advised, especially for patients taking diuretics or those with fluid depletion. Drug interactions may occur if taken with other antihypertensive medications or specific drugs, so inform your doctor or pharmacist about any other medications you are taking. Women who are pregnant or planning to become pregnant should not use this medication, and it is advisable to avoid it while breastfeeding. Safety and efficacy have not been established for children or adolescents under 18 years of age, and its use is not recommended in this population. In cases of overdose, severe hypotension, decreased consciousness, shock, etc. may occur, so it is important to adhere to the prescribed dosage and seek emergency care if unusual symptoms appear. This medication should be stored out of reach of children and should not be transferred to another container to maintain quality.

Side effects

Headache, dizziness, anxiety, insomnia, dyspepsia, diarrhea, gastritis, epigastric pain, nausea, palpitations, flushing, itching, hives, cough, increase in alanine aminotransferase, hyperlipidemia, hypertriglyceridemia, diabetes, sensory impairment, chest pain, chest discomfort, myalgia, nasopharyngitis, upper respiratory infection, oropharyngeal pain, pharyngitis, viral infection, fatigue, rhinitis, sinusitis, abdominal pain, colic, pharyngitis, arthralgia, edema, asthenia, erythema, decreased libido, vertigo, decreased red blood cell volume, decreased hemoglobin, increased serum creatinine, increased potassium, increased total bilirubin, elevated liver function tests, increased BUN, dizziness, rigidity, weakness, tinnitus, hypertonia, decreased motor function, confusion, rash, intestinal vascular edema, peripheral edema, tachycardia, hypotension, angina, drowsiness, neuroses, vomiting, polyuria, frequency of urination, gingival hypertrophy, gingival hypertrophy due to prolonged use, rash, trembling, dry mouth, abdominal bloating, erectile dysfunction, arrhythmia, cold sweat, pricking sensation in the skin, premature contractions, tongue rigidity, increased ventricular premature contractions

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent exposure to air or moisture and should be kept at a safe temperature between 1 degree and 30 degrees Celsius. By storing it this way, the effectiveness of the medication can be maintained, and deterioration can be prevented.

Appearance and packaging

Appearance

Pink oval film-coated tablet

Package unit

100 tablets (10 tablets/PTP x 10)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.